(Q42438517)

31 October 2017

The absence of an apolipoprotein epsilon4 allele is associated with a more aggressive form of Alzheimer's disease (English)

1 reference

31 October 2017

0 references

1

Stern Y

1 reference

31 October 2017

13

Mayeux R

1 reference

31 October 2017

7

Marder K

1 reference

31 October 2017

6

Bell K

1 reference

31 October 2017

Brandt J

2

1 reference

31 October 2017

Albert M

3

1 reference

31 October 2017

Jacobs DM

4

1 reference

31 October 2017

Liu X

5

1 reference

31 October 2017

Sano M

8

1 reference

31 October 2017

Albert S

9

1 reference

31 October 2017

Del-Castillo Castenada C

10

1 reference

31 October 2017

Bylsma F

11

1 reference

31 October 2017

Tycko B

12

1 reference

31 October 2017

language of work or name

1 reference

1 May 1997

1 reference

31 October 2017

1 reference

31 October 2017

41

1 reference

31 October 2017

5

1 reference

31 October 2017

615-620

1 reference

Apolipoprotein E, survival in Alzheimer's disease patients, and the competing risks of death and Alzheimer's disease.

31 October 2017

1 reference

https://api.crossref.org/works/10.1002%2FANA.410410510

Clinical diagnosis of Alzheimer's disease: report of the NINCDS-ADRDA Work Group under the auspices of Department of Health and Human Services Task Force on Alzheimer's Disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FANA.410410510

Depression, intellectual impairment, and Parkinson disease.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FANA.410410510

Early diagnosis of herpes simplex encephalitis by MRI.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FANA.410410510

Cerebral blood flow in dementia

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FANA.410410510

Interrater reliability of extrapyramidal signs in a group assessed for dementia.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FANA.410410510

The Consortium to Establish a Registry for Alzheimer's Disease (CERAD). Part II. Standardization of the neuropathologic assessment of Alzheimer's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FANA.410410510

Association of apolipoprotein E allele epsilon 4 with late-onset familial and sporadic Alzheimer's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FANA.410410510

Apolipoprotein e4 allele and cognitive decline in elderly men.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FANA.410410510

Cumulative risks of developing extrapyramidal signs, psychosis, or myoclonus in the course of Alzheimer's disease.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FANA.410410510

Study of Alzheimer's dementia patients with parkinsonian features

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FANA.410410510

Predictors of disease course in patients with probable Alzheimer's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FANA.410410510

Predictors of cognitive and functional progression in patients with probable Alzheimer's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FANA.410410510

21 January 2018

Identifiers

DOI

10.1002/ANA.410410510

1 reference

31 October 2017

1 reference